zoledronic acid has been researched along with Adenocarcinoma Of Kidney in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 16 (34.78) | 29.6817 |
2010's | 28 (60.87) | 24.3611 |
2020's | 2 (4.35) | 2.80 |
Authors | Studies |
---|---|
Gao, Q; Guo, J; You, H; Zhao, Y; Zhu, H | 1 |
Harada, H; Hayakawa, K; Katagiri, H; Miyazawa, K; Nagakura, H; Nakamura, N; Nozaki, M; Ogawa, H; Shikama, N; Uchida, N; Wada, H; Yamada, K | 1 |
Harada, H; Hosaka, S; Katagiri, H; Murata, H; Niwakawa, M; Takahashi, M; Wasa, J | 1 |
Omrčen, T; Rini, B; Schmidinger, M; Sella, A; Szczylik, C; Torday, L; Vrdoljak, E | 1 |
Agerbaek, M; Donskov, F; Fode, K; Folkmar, TB; Smidt-Hansen, T | 1 |
Fujii, Y; Kihara, K; Kijima, T; Koga, F; Tatokoro, M; Yoshida, S | 1 |
Bahleda, R; Escudier, B; Gueutin, V; Izzedine, H; Rouvier, P; Soria, JC; Varga, A | 1 |
Alcaraz, A; Alvarez-Ossorio, JL; Bellmunt, J; Calderero, V; Carles, J; Chirivella, I; Climent, M; Comet-Batlle, J; Contreras, JA; de la Piedra, C; Esteban, E; González-Del Alba, A; González-Enguita, C; González-Gragera, B; González-López, R; Lara, PC; Lassa, A; León-Mateos, L; Mahillo-Fernández, I; Mañas, A; Mellado, B; Méndez, MJ; Meseguer, C; Morote, J; Murias, A; Samper, P; Segarra, J; Unda, M; Vázquez, F | 1 |
Levin, L; Luder, L | 1 |
Choueiri, TK; Heng, DY; Lin, X; McKay, RR; Perkins, JJ; Simantov, R | 1 |
Froehner, M; Hakenberg, OW; Hölscher, T; Wirth, MP | 1 |
Broom, RJ; Deva, S; Duffey, S; Findlay, MP; Fong, PC; Forgeson, G; Grey, A; Hanning, FJ; Harris, DL; Hinder, V; Jameson, MB; North, RT; O'Donnell, A; Pollard, S; Proctor, J; Sharples, K | 1 |
Bedogni, A; Bettini, G; Bonacina, R; Campisi, G; Di Fede, O; Fusco, V; Guglielmini, P; Lo Re, G; Merigo, E; Paglino, C; Porta, C; Saia, G; Scoletta, M; Vescovi, P | 1 |
Boychuk, SI; Dedkov, AG; Yugrinova, LG | 1 |
Arima, S; Hayakawa, K; Hoshinaga, K; Kusaka, M; Maruyama, T; Miyakawa, S; Mori, S; Sasaki, H; Shiroki, R | 1 |
Chow, E; Ehrlich, L; Hird, AE; Ko, YJ; Probyn, L; Sinclair, E; Yip, D | 1 |
Fujii, Y; Fukui, I; Kijima, T; Masuda, H; Okubo, Y; Suyama, T; Yamamoto, S; Yonese, J | 1 |
Costa, F; Kalkner, KM; Lennartsson, L; Lennernas, B; Linder, S; Nilsson, S; Sandstrom, P; Schwarz, S; Ullen, A | 1 |
Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B | 1 |
Izumi, K; Konaka, H; Miwa, S; Mizokami, A; Namiki, M; Nohara, T | 1 |
Hasegawa, Y; Matsubara, A; Mita, K; Ohdan, H | 1 |
Kobayashi, H; Minato, N; Shimmura, H; Tanabe, K; Tanaka, Y | 1 |
Bozas, G; Maraveyas, A; Ramasamy, V; Roy, A | 1 |
Eastham, JA; Saad, F | 1 |
Botteman, MF; Chen, YM; Foley, I; Kaura, S; Meijboom, M; Stephens, JM | 1 |
Cagli, B; Intagliata, S; Onetti Muda, A; Perrone, G; Persichetti, P; Santini, D; Segreto, F; Tonini, G | 1 |
Brown, J; Clark, K; Gregory, W; Hayward, K; Jagdev, S; McParland, L; Newsham, A; Rogerson, S; Selby, P; Woodward, E | 1 |
Kobayashi, H; Minato, N; Tanabe, K; Tanaka, Y; Yagi, J | 1 |
Eickhoff, JC; Horvath, DL; Kaikobad, MR; Lang, JM; Liu, G; Malkovsky, M; McNeel, DG; Staab, MJ; Wallace, M; Wilding, G | 1 |
Haygood, TM; Jonasch, E; Manoukian, GE; Qiao, W; Tannir, NM; Tu, SM | 1 |
Fujita, M; Nakamura, T; Okamura, N; Sawada, K; Tohi, M; Yagami, T; Yamamori, M; Yamamoto, Y | 1 |
Botteman, MF; Carter, JA; Joshi, AD; Kaura, S | 1 |
Birkholz, K; Gruenwald, V; Kindler, M; May, C; Miller, K; Ruebel, A; Schultze-Seemann, W; Schulze, M; Stenzl, A; Strauss, A; Tunn, UW; Wirth, MP; Zantl, N | 1 |
Chen, AH; Tu, SM | 1 |
Boikos, SA; Hammers, HJ | 1 |
Fujii, Y; Fukui, I; Kitsukawa, S; Takahashi, S; Urakami, S; Yamamoto, S; Yasuda, Y; Yonese, J; Yuasa, T | 1 |
Hiraga, H; Isu, K; Kamata, H; Minami, A; Shinohara, N; Takeda, N | 1 |
Lipton, A; Seaman, J; Zheng, M | 1 |
La Cesa, A; Santini, D; Tonini, G; Vincenzi, B | 1 |
Bukowski, RM; Colombo-Berra, A; Lipton, A; Rosen, L; Urbanowitz, G; Zheng, M | 1 |
Michaelson, MD; Rosenthal, DI; Smith, MR | 1 |
Ciccarelli, R; Fedele, S; Lo Muzio, L; Lo Russo, L; Mignogna, MD | 1 |
Do, KA; Jonasch, E; Lin, P; Lin, SH; Mathew, P; Pagliaro, LC; Rhines, L; Siefker-Radtke, A; Tannir, N; Tibbs, R; Tu, SM | 1 |
Anderson, C; Birchall, L; Harrington, K; Meyer, B; Pandha, H; Relph, K; Wilson, N | 1 |
Newman, SA; Phillips, PM | 1 |
Fujii, Y; Fukui, I; Kijima, T; Okubo, Y; Suyama, T; Yonese, J | 1 |
6 review(s) available for zoledronic acid and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Bisphosphonates and vascular endothelial growth factor-targeted drugs in the treatment of patients with renal cell carcinoma metastatic to bone.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sorafenib; Sulfonamides; Sunitinib; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2013 |
Treatment of bone metastases in urologic malignancies.
Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Cisplatin; Denosumab; Diphosphonates; Humans; Imidazoles; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prostatic Neoplasms; Quality of Life; Radiosurgery; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms; Zoledronic Acid | 2014 |
Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Cancer Treated With Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Indoles; Italy; Jaw; Kidney Neoplasms; Male; Middle Aged; Osteonecrosis; Pyrroles; Retrospective Studies; Sunitinib; Zoledronic Acid | 2015 |
Zoledronic acid use in patients with bone metastases from renal cell carcinoma or bladder cancer.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease Progression; Humans; Imidazoles; Kidney Neoplasms; Survival Analysis; Urinary Bladder Neoplasms; Zoledronic Acid | 2010 |
Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours.
Topics: Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Carcinoma, Renal Cell; Cost-Benefit Analysis; Diphosphonates; Drug Costs; Europe; Health Care Costs; Humans; Imidazoles; Kidney Neoplasms; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Zoledronic Acid | 2012 |
Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid.
Topics: Bone Diseases; Bone Neoplasms; Bone Resorption; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Neoplasm Metastasis; Osteolysis; Zoledronic Acid | 2004 |
9 trial(s) available for zoledronic acid and Adenocarcinoma Of Kidney
Article | Year |
---|---|
A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Renal Cell; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Treatment Outcome; Zoledronic Acid | 2021 |
Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial.
Topics: Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Collagen Type I; Diphosphonates; Everolimus; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Peptides; Prospective Studies; Sirolimus; Treatment Outcome; Zoledronic Acid | 2015 |
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; CD3 Complex; Cytotoxicity, Immunologic; Diphosphonates; Female; Humans; Imidazoles; Immunotherapy, Adoptive; Interleukin-2; Kidney Neoplasms; Lung Neoplasms; Lymphocyte Activation; Male; Middle Aged; Neoplasm Staging; Organophosphorus Compounds; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Zoledronic Acid | 2011 |
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Separation; Diphosphonates; Female; Flow Cytometry; Humans; Imidazoles; Immunotherapy; Interleukin-2; Kidney Neoplasms; Lymphocyte Activation; Male; Middle Aged; Pilot Projects; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Zoledronic Acid | 2011 |
Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Biomarkers, Tumor; Bone Neoplasms; Bone Remodeling; Carcinoma, Renal Cell; Diphosphonates; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Imidazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Pilot Projects; Pyrroles; Zoledronic Acid | 2011 |
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Female; Fractures, Spontaneous; Humans; Imidazoles; Kaplan-Meier Estimate; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Spinal Cord Compression; Tomography, X-Ray Computed; Zoledronic Acid | 2012 |
Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease Progression; Female; Fractures, Bone; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Placebos; Retrospective Studies; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid | 2003 |
Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid.
Topics: Bone Diseases; Bone Neoplasms; Bone Resorption; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Neoplasm Metastasis; Osteolysis; Zoledronic Acid | 2004 |
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Interferon-gamma; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Thalidomide; Zoledronic Acid | 2006 |
32 other study(ies) available for zoledronic acid and Adenocarcinoma Of Kidney
Article | Year |
---|---|
TIGIT-expressing zoledronate-specific γδ T cells display enhanced antitumor activity.
Topics: Carcinoma; Carcinoma, Renal Cell; Cytokines; Humans; Kidney Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; Receptors, Immunologic; Zoledronic Acid | 2022 |
Radiotherapy combined with zoledronate can reduce skeletal-related events in renal cell carcinoma patients with bone metastasis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Chemoradiotherapy; Female; Fractures, Spontaneous; Humans; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Spinal Cord Compression; Sunitinib; Survival Rate; Treatment Outcome; Zoledronic Acid | 2018 |
Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Cohort Studies; Diphosphonates; Everolimus; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Imidazoles; Indazoles; Indoles; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Radiography, Panoramic; Retrospective Studies; Sirolimus; Sorafenib; Spinal Cord Compression; Sulfonamides; Sunitinib; Survival Rate; Zoledronic Acid | 2013 |
Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1.
Topics: Apoptosis; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; Diphosphonates; Gamma Rays; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Kidney Neoplasms; Organ Specificity; Radiation Tolerance; Radiation-Sensitizing Agents; RNA, Small Interfering; Signal Transduction; STAT1 Transcription Factor; Zoledronic Acid | 2013 |
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven.
Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Renal Cell; Cisplatin; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Glutamates; Guanine; Humans; Imidazoles; Indoles; Interferons; Kidney Tubules; Lung Neoplasms; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Necrosis; Nephrectomy; Pemetrexed; Prednisone; Pyrroles; Sunitinib; TOR Serine-Threonine Kinases; Vincristine; Zoledronic Acid | 2013 |
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, Tumor; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Carcinoma, Renal Cell; Collagen Type I; Diphosphonates; Disease Progression; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Peptide Fragments; Procollagen; Prospective Studies; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Zoledronic Acid | 2013 |
Jaw lesion and discomfort.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Carcinoma, Renal Cell; Chlorhexidine; Diphosphonates; Doxycycline; Female; Gingival Diseases; Humans; Imidazoles; Kidney Neoplasms; Mandible; Middle Aged; Mouthwashes; Oral Hygiene; Pain; Zoledronic Acid | 2013 |
Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma.
Topics: Aged; Antineoplastic Agents; Axitinib; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease-Free Survival; Female; Humans; Hypocalcemia; Imidazoles; Indazoles; Indoles; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Pamidronate; Phenylurea Compounds; Prognosis; Pyrroles; Renal Insufficiency; Retrospective Studies; Sirolimus; Sorafenib; Sunitinib; Survival Rate; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2014 |
[PREVENTION OF THE BONES METASTASES OCCURRENCE IN THE PATIENTS WITH RENAL-CELL CANCER].
Topics: Acid Phosphatase; Aged; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Drug Administration Schedule; Female; Gene Expression; Humans; Imidazoles; Isoenzymes; Kidney Neoplasms; Male; Middle Aged; Radiography; Tartrate-Resistant Acid Phosphatase; Tomography, Emission-Computed; Treatment Outcome; Zoledronic Acid | 2015 |
[Zoledronic acid for bone metastases due to advanced renal cell carcinoma under chronic hemodialysis--a report of two cases].
Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Calcium; Carcinoma, Renal Cell; Chronic Disease; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Infusions, Intravenous; Interleukin-2; Kidney Failure, Chronic; Kidney Neoplasms; Male; Middle Aged; Monitoring, Physiologic; Renal Dialysis; Thalidomide; Zoledronic Acid | 2008 |
Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature.
Topics: Adult; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Diphosphonates; Humans; Imidazoles; Indoles; Kidney Neoplasms; Male; Nephrectomy; Pain Management; Palliative Care; Pyrroles; Quality of Life; Sunitinib; Zoledronic Acid | 2008 |
Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate.
Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Zoledronic Acid | 2009 |
Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.
Topics: Apoptosis; Bone Density Conservation Agents; Carcinoma, Renal Cell; Caspases; Cell Line, Tumor; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Fluorometry; Humans; Imidazoles; Kidney Neoplasms; Zoledronic Acid | 2009 |
[Primary hyperparathyroidism. An alternative to the surgery].
Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid | 2009 |
A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.
Topics: Adult; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Pleural Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid | 2009 |
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Immunosuppressive Agents; Incidental Findings; Interferon-alpha; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Nephrectomy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Radiotherapy, Adjuvant; Sorafenib; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid | 2009 |
Complete remission of lung metastasis following adoptive immunotherapy using activated autologous gammadelta T-cells in a patient with renal cell carcinoma.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Carcinoma, Renal Cell; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Immunotherapy, Adoptive; Interferon-gamma; Interleukin-2; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; T-Lymphocytes; Transplantation, Autologous; Treatment Outcome; Zoledronic Acid | 2010 |
Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Diphosphonates; Drug Synergism; Humans; Imidazoles; Indoles; Infusions, Intravenous; Kidney Neoplasms; Male; Mandibular Diseases; Middle Aged; Neoplasm Staging; Osteonecrosis; Pyrroles; Sacrum; Spinal Neoplasms; Sunitinib; Zoledronic Acid | 2010 |
Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom.
Topics: Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Cost-Benefit Analysis; Diphosphonates; Female; Financing, Government; France; Germany; Humans; Imidazoles; Male; Models, Economic; Neoplasm Staging; Quality-Adjusted Life Years; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; United Kingdom; Zoledronic Acid | 2011 |
Recurrent scrotal hemangiomas during treatment with sunitinib.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Genital Neoplasms, Male; Hemangioma; Humans; Imidazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Recurrence; Scrotum; Skin Neoplasms; Sunitinib; Zoledronic Acid | 2010 |
Skeletal complications and survival in renal cancer patients with bone metastases.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Spinal Cord Compression; Survival Analysis; Time Factors; Zoledronic Acid | 2011 |
Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Male; Metabolic Networks and Pathways; Mevalonic Acid; Mice; Mice, Inbred BALB C; Xenograft Model Antitumor Assays; Zoledronic Acid | 2012 |
Re: Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Zoledronic Acid | 2012 |
Denosumab for the treatment of bisphosphonate-refractory hypercalcemia.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Neoplasms; Carcinoma, Renal Cell; Denosumab; Diphosphonates; Disease Progression; Drug Resistance; Fatal Outcome; Humans; Hypercalcemia; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Parathyroid Hormone; Risk Assessment; Zoledronic Acid | 2012 |
Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma.
Topics: Aged; Bone Neoplasms; Calcium; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Zoledronic Acid | 2013 |
Zoledronic acid enhances the effect of radiotherapy for bone metastases from renal cell carcinomas: more than a 24-month median follow-up.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease-Free Survival; Female; Follow-Up Studies; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Young Adult; Zoledronic Acid | 2012 |
Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma.
Topics: Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasm Staging; Prognosis; Sampling Studies; Survival Analysis; Treatment Outcome; Zoledronic Acid | 2004 |
Long-term bisphosphonate treatment of bone metastases from renal cell carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Male; Zoledronic Acid | 2004 |
Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.
Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Hyperbaric Oxygenation; Imidazoles; Jaw; Kidney Neoplasms; Male; Osteonecrosis; Pain; Zoledronic Acid | 2006 |
Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Pamidronate; Tumor Cells, Cultured; Zoledronic Acid | 2006 |
Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma.
Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Glucocorticoids; Humans; Imidazoles; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Orbital Pseudotumor; Prednisone; Tomography, X-Ray Computed; Zoledronic Acid | 2008 |
Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Pamidronate; Zoledronic Acid | 2008 |